Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia

Journal of Obstetrics and Gynaecology Research

Volumn 41, Issue 5, 2015, Pages 662-669

  Amarasekara, Ranmalee ^a   Jayasekara, Rohan W ^a   Senanayake, Hemantha ^a   Dissanayake, Vajira H W ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

molecular genetics; obstetric infections bacterial; pre eclampsia eclampsia

Indexed keywords

RNA 16S;

ADULT; AMNION FLUID; ANOXYBACILLUS; ARTICLE; BACILLUS CEREUS; BODY MASS; CESAREAN SECTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESCHERICHIA; FEMALE; GENOTYPE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; LISTERIA; MAJOR CLINICAL STUDY; MICROBIOME; NONHUMAN; PLACENTA; PORPHYROMONAS; PREECLAMPSIA; PREGNANT WOMAN; PREVOTELLA; PRIMIPARA; SALMONELLA; SYSTOLIC BLOOD PRESSURE; VARIOVORAX; BACTERIUM; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PREGNANCY; YOUNG ADULT;

ADULT; BACTERIA; FEMALE; HUMANS; MICROBIOTA; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 84928585458     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12619     Document Type: Article

References (27)

1. Ghulmiyyah L, Sibai B,. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012; 36: 56-59.
2. Senanayake H, Goonewardene M, Ranatunga A, Hattotuwa R, Amarasekera S, Amarasinghe I,. Achieving millennium development goals 4 and 5 in Sri Lanka. BJOG 2011; 118 (Suppl 2): 78-87.
3. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ,. Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011; 2011: 214365-214372.
4. Duley L,. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99: 547-553.
5. Dyer RA, Piercy JL, Reed AR,. The role of the anaesthetist in the management of the pre-eclamptic patient. Curr Opin Anaesthesiol 2007; 20: 168-174.
6. Zhang J, Meikle S, Trumble A,. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22: 203-212.
7. Lee CJ, Hsieh TT, Chiu TH, Chen KC, Lo LM, Hung TH,. Risk factors for pre-eclampsia in an Asian population. Int J Gynaecol Obstet 2000; 70: 327-333.
8. Dekker GA, Robillard PY, Hulsey TC,. Immune maladaptation in the etiology of preeclampsia: A review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998; 53: 377-382.
9. Conde-Agudelo A, Villar J, Lindheimer M,. Maternal infection and risk of preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198: 7-22.
10. Bell MJ,. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs 2010; 39: 510-518.
11. Bdolah Y, Karumanchi SA, Sachs BP,. Recent advances in understanding of preeclampsia. Croat Med J 2005; 46: 728-736.
12. Walker JJ,. Pre-eclampsia. Lancet 2000; 356: 1260-1265.
13. Villar J, Carroli G, Wojdyla D, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006; 194: 921-931.
14. Rustveld LO, Kelsey SF, Sharma R,. Association between maternal infections and preeclampsia: A systematic review of epidemiologic studies. Matern Child Health J 2008; 12: 223-242.
15. von Dadelszen P, Magee LA,. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81: 642-648.
16. Goulis DG, Chappell L, Gibbs RG, et al. Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. BJOG 2005; 112: 299-305.
17. Heine RP, Ness RB, Roberts JM,. Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet Gynecol 2003; 101: 221-226.
18. Harwich MD Jr, Serrano MG, Fettweis JM, et al. Genomic sequence analysis and characterization of Sneathia amnii sp. nov. BMC Genomics 2012; 13 (Suppl 8): S4.
19. Contreras A, Herrera JA, Soto JE, Arce RM, Jaramillo A, Botero JE,. Periodontitis is associated with preeclampsia in pregnant women. J Periodontol 2006; 77: 182-188.
20. Barak S, Oettinger-Barak O, Machtei EE, Sprecher H, Ohel G,. Evidence of periopathogenic microorganisms in placentas of women with preeclampsia. J Periodontol 2007; 78: 670-676.
21. DiGiulio DB, Gervasi M, Romero R, et al. Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods. J Perinat Med 2010; 38: 503-513.
22. Faas MM,. The low dose of endotoxin-infused pregnant rat: Aspects of the pathogenesis of a pre-eclampsia like disease (Dissertation). Groningen: University of Groningen, 1995.
23. Von Dadelszen P, Magee LA, Marshall JC, Rotstein OD,. The maternal syndrome of preeclampsia: A forme fruste of the systemic inflammatory response syndrome. Sepsis 2000; 4: 43-47.
24. Janda JM, Abbott SL,. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: Pluses, perils, and pitfalls. J Clin Microbiol 2007; 45: 2761-2764.
25. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM,. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX-XIV.
26. Dissanayake VH, Morgan L, Broughton Pipkin F, et al. The urine protein heat coagulation test-a useful screening test for proteinuria in pregnancy in developing countries: A method validation study. BJOG 2004; 111: 491-494.
27. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75: 7537-7541.